CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Raymond T. Keane, Esq., to the newly created position of vice president, general counsel and chief compliance officer. Mr. Keane, who most recently was senior counsel, worldwide medicines at Bristol-Myers Squibb (BMS), will lead the Company’s corporate legal function and be responsible for expanding and overseeing ARIAD’s commercial compliance programs. He will also assume responsibility for the Company’s legal activities relating to the commercialization of its growing pipeline of oncology product candidates.
